B-Secur has developed a patented software technique that uses an individual’s electrocardiogram (ECG) to enable secure identification while simultaneously providing health and wellness insights. The company embeds medical-grade ECG recording into consumer devices such as smartwatches, cars and clothing and is already selling to some of the world’s largest technology companies. B-Secur has been granted FDA clearance for its technology and has signed its first contract with a US-based medical device manufacturer. It employs over 45 scientists and engineers and has offices in Belfast’s Innovation Centre, Catalyst. The company intends to use new funding to cement traction in the wearable space, accelerate entry into the medical device market, and hire additional staff in Belfast and the US. B-Secur has developed a software technique that uses an individual’s unique heartbeat pattern (ECG) to securely identify users and deliver health and wellness insights. The company embeds this technology into smartwatches, cars and clothing and is already selling to some of the world’s largest technology companies. B-Secur has signed significant contracts with international customers in recent months. The company intends to use the new funds to expand its business reach. Led by CEO Alan Foreman, B-Secur is based in Belfast with offices in Belfast’s Innovation Centre, Catalyst, and employs over 35 scientists and engineers. It plans to hire additional staff in Belfast and engineering staff in customer regions including the US and China. Led by CEO Alan Foreman, B-Secur provides software solutions that use ECG/EKG biometrics for user authentication and to deliver health and wellness metrics. The company leverages the unique electrical signal of an individual's heartbeat (ECG) as a means of personal authentication and physiological monitoring. It launched the Heartkey brand at CES to combine unique user identification with medical-grade heart rate, stress and fatigue monitoring. Heartkey is being positioned for everyday applications such as in-vehicle monitoring and real-time health monitoring in the home, and for embedding in wearables. B-Secur is partnering with motoring manufacturers, global wearable and fitness tracker firms, and semiconductor manufacturers to integrate Heartkey into multiple technologies. The company employs more than 35 staff at its Belfast headquarters and recently closed a funding round to support expansion of its business reach. B-Secur develops a patented biometric technology that uses an individual’s unique heartbeat pattern (ECG) to authenticate identity. The company positions ECG as an internal biometric to reduce hacking and spoofing risks and improve security and convenience. Led by CEO Alan Foreman, B-Secur serves customers across automotive, financial services, access control, smart cities and buildings, and healthcare. Its semiconductor industry work is at the core of its technology development process. The company operates in the UK, Ireland and the US. B-Secur recently raised £3.5M to support growth and continued investment in science and engineering in Northern Ireland and beyond.

Total raised

$24M

Funding rounds

4

Latest round

Equity

Latest activity

Nov 2021